Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombocytopenia | 8 | 2021 | 1179 | 1.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2021 | 283 | 0.710 |
Why?
|
| Benzoates | 1 | 2020 | 213 | 0.630 |
Why?
|
| Hydrazines | 1 | 2020 | 223 | 0.620 |
Why?
|
| Thrombopoietin | 6 | 2023 | 225 | 0.610 |
Why?
|
| Anemia, Aplastic | 1 | 2020 | 231 | 0.600 |
Why?
|
| Plasma | 1 | 2020 | 585 | 0.550 |
Why?
|
| Receptors, Fc | 5 | 2021 | 537 | 0.510 |
Why?
|
| Autoantibodies | 2 | 2021 | 2121 | 0.430 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 3 | 2023 | 246 | 0.430 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2023 | 3740 | 0.390 |
Why?
|
| Pyrazoles | 1 | 2020 | 2028 | 0.330 |
Why?
|
| Receptors, Leukotriene B4 | 2 | 2003 | 93 | 0.260 |
Why?
|
| Leukotriene B4 | 2 | 2003 | 281 | 0.240 |
Why?
|
| Thiophenes | 1 | 2023 | 570 | 0.160 |
Why?
|
| Bilirubin | 1 | 2020 | 438 | 0.150 |
Why?
|
| Hematologic Agents | 1 | 2018 | 39 | 0.150 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2003 | 1801 | 0.130 |
Why?
|
| Myeloproliferative Disorders | 1 | 2022 | 616 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 1815 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 837 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1519 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1162 | 0.110 |
Why?
|
| Platelet Count | 3 | 2023 | 787 | 0.110 |
Why?
|
| Hemorrhage | 2 | 2022 | 3467 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1605 | 0.090 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 1907 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2018 | 1043 | 0.090 |
Why?
|
| Peritonitis | 2 | 2003 | 368 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2003 | 3114 | 0.080 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 13676 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2003 | 660 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1480 | 0.080 |
Why?
|
| Neoplasms | 4 | 2022 | 22371 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4206 | 0.080 |
Why?
|
| Heart Failure | 2 | 2022 | 11879 | 0.070 |
Why?
|
| Receptors, Thrombopoietin | 2 | 2018 | 159 | 0.070 |
Why?
|
| Thrombosis | 1 | 2020 | 2957 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 4262 | 0.060 |
Why?
|
| Leukapheresis | 1 | 2006 | 150 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 5176 | 0.060 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2003 | 141 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| L-Selectin | 1 | 2001 | 212 | 0.050 |
Why?
|
| Female | 10 | 2022 | 397192 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9755 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2003 | 23645 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 2000 | 197 | 0.040 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2020 | 144 | 0.040 |
Why?
|
| Humans | 15 | 2023 | 768166 | 0.040 |
Why?
|
| Integrins | 1 | 2003 | 842 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 171504 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
| Middle Aged | 7 | 2021 | 223492 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15662 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2003 | 1377 | 0.030 |
Why?
|
| Thiazoles | 1 | 2023 | 1542 | 0.030 |
Why?
|
| Jehovah's Witnesses | 1 | 2015 | 13 | 0.030 |
Why?
|
| Eosinophils | 1 | 2000 | 952 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 301 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1999 | 910 | 0.030 |
Why?
|
| Diarrhea | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 575 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2023 | 2479 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5902 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2022 | 81762 | 0.030 |
Why?
|
| Acute Disease | 1 | 2003 | 7243 | 0.030 |
Why?
|
| Adult | 7 | 2023 | 223646 | 0.020 |
Why?
|
| Hepacivirus | 1 | 1999 | 1344 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 1999 | 1032 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2003 | 14488 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1999 | 2872 | 0.020 |
Why?
|
| Male | 8 | 2022 | 364719 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 10760 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 59629 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3858 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4978 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2003 | 22379 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2015 | 1305 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 13014 | 0.020 |
Why?
|
| Kidney | 1 | 2021 | 7064 | 0.020 |
Why?
|
| Lymphocyte Transfusion | 1 | 2006 | 232 | 0.020 |
Why?
|
| Blood Volume | 1 | 2006 | 545 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65371 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2006 | 794 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 2001 | 40 | 0.010 |
Why?
|
| Mice | 3 | 2003 | 82029 | 0.010 |
Why?
|
| Microvilli | 1 | 2001 | 235 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 60066 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2022 | 24315 | 0.010 |
Why?
|
| Thioglycolates | 1 | 2000 | 37 | 0.010 |
Why?
|
| Calmodulin | 1 | 2001 | 241 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 30010 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2001 | 826 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
| Venules | 1 | 2000 | 161 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 2001 | 386 | 0.010 |
Why?
|
| Dipeptides | 1 | 2001 | 386 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 244 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 1999 | 182 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2001 | 483 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20760 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 841 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2006 | 2381 | 0.010 |
Why?
|
| Animals | 3 | 2003 | 169246 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15832 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 1582 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 74944 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3772 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 2937 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 6329 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2000 | 3096 | 0.010 |
Why?
|
| Leukocytes | 1 | 2001 | 2035 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4580 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3728 | 0.010 |
Why?
|
| Neutrophils | 1 | 2000 | 3786 | 0.000 |
Why?
|
| Cell Line | 1 | 2001 | 15597 | 0.000 |
Why?
|
| Calcium | 1 | 2000 | 5792 | 0.000 |
Why?
|
| Recurrence | 1 | 1999 | 8509 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 15454 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 18349 | 0.000 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_